Cargando…
Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
Autores principales: | GNESOTTO, Laura, MIOSO, Guido, BARDAZZI, Federico, FILIPPI, Federica, DI LERNIA, Vito, MOTOLESE, Alberto, DI NUZZO, Sergio, CONTI, Andrea, ARGINELLI, Federica, CORAZZA, Monica, ODORICI, Giulia, BORGHI, Alessandro, GISONDI, Paolo, NALDI, Luigi, DAPAVO, Paolo, PARODI, Aurora, BURLANDO, Martina, PIASERICO, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077142/ https://www.ncbi.nlm.nih.gov/pubmed/36987538 http://dx.doi.org/10.2340/actadv.v103.4526 |
Ejemplares similares
-
Dimethyl fumarate treatment for psoriasis in a real‐life setting: A multicentric retrospective study
por: Corazza, Monica, et al.
Publicado: (2021) -
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
por: Gisondi, Paolo, et al.
Publicado: (2021) -
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence
por: Piaserico, Stefano, et al.
Publicado: (2022) -
Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy
por: Piaserico, Stefano, et al.
Publicado: (2020) -
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review
por: Gisondi, Paolo, et al.
Publicado: (2021)